DCF — MERITUS MEDICAL CENTER
Enterprise Value: $-15.5M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-15.5M
Enterprise Value
$-15.2M
PV of Cash Flows
$-0.3M
PV of Terminal Value
$-0.6M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $408.1M | $8.4M | 2.0% | $-8.9M | $-8.1M |
| Year 2 | $420.3M | $12.8M | 3.0% | $-5.6M | $-4.6M |
| Year 3 | $432.9M | $17.5M | 4.0% | $-2.5M | $-1.9M |
| Year 4 | $445.9M | $20.3M | 5.0% | $-0.9M | $-0.6M |
| Year 5 | $459.3M | $22.0M | 5.0% | $-0.0M | $-0.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-15.5M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$396.2M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.015487091522296447
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5